Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs.
Identifieur interne : 002651 ( PubMed/Checkpoint ); précédent : 002650; suivant : 002652Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs.
Auteurs : Yi Shi [République populaire de Chine] ; De Hua Yang ; Jie Xiong ; Jie Jia ; Bing Huang ; You Xin JinSource :
- Cell research [ 1001-0602 ] ; 2005.
Descripteurs français
- KwdFr :
- Animaux, Cellules Vero, Clonage moléculaire, Interférence par ARN, Petit ARN interférent (pharmacologie), Protéines de l'enveloppe virale (antagonistes et inhibiteurs), Protéines de l'enveloppe virale (biosynthèse), Protéines de l'enveloppe virale (génétique), Protéines de la matrice virale (antagonistes et inhibiteurs), Protéines de la matrice virale (biosynthèse), Protéines de la matrice virale (génétique), Protéines nucléocapside (antagonistes et inhibiteurs), Protéines nucléocapside (biosynthèse), Protéines nucléocapside (génétique), Protéines virales structurales (antagonistes et inhibiteurs), Protéines virales structurales (biosynthèse), Protéines virales structurales (génétique), Protéines à fluorescence verte (métabolisme), Régulation de l'expression des gènes viraux, Virus du SRAS (), Virus du SRAS (génétique), Virus du SRAS (métabolisme).
- MESH :
- antagonistes et inhibiteurs : Protéines de l'enveloppe virale, Protéines de la matrice virale, Protéines nucléocapside, Protéines virales structurales.
- biosynthèse : Protéines de l'enveloppe virale, Protéines de la matrice virale, Protéines nucléocapside, Protéines virales structurales.
- génétique : Protéines de l'enveloppe virale, Protéines de la matrice virale, Protéines nucléocapside, Protéines virales structurales, Virus du SRAS.
- métabolisme : Protéines à fluorescence verte, Virus du SRAS.
- pharmacologie : Petit ARN interférent.
- Animaux, Cellules Vero, Clonage moléculaire, Interférence par ARN, Régulation de l'expression des gènes viraux, Virus du SRAS.
English descriptors
- KwdEn :
- Animals, Chlorocebus aethiops, Cloning, Molecular, Gene Expression Regulation, Viral, Green Fluorescent Proteins (metabolism), Nucleocapsid Proteins (antagonists & inhibitors), Nucleocapsid Proteins (biosynthesis), Nucleocapsid Proteins (genetics), RNA Interference, RNA, Small Interfering (pharmacology), SARS Virus (drug effects), SARS Virus (genetics), SARS Virus (metabolism), Vero Cells, Viral Envelope Proteins (antagonists & inhibitors), Viral Envelope Proteins (biosynthesis), Viral Envelope Proteins (genetics), Viral Matrix Proteins (antagonists & inhibitors), Viral Matrix Proteins (biosynthesis), Viral Matrix Proteins (genetics), Viral Structural Proteins (antagonists & inhibitors), Viral Structural Proteins (biosynthesis), Viral Structural Proteins (genetics).
- MESH :
- chemical , antagonists & inhibitors : Nucleocapsid Proteins, Viral Envelope Proteins, Viral Matrix Proteins, Viral Structural Proteins.
- chemical , biosynthesis : Nucleocapsid Proteins, Viral Envelope Proteins, Viral Matrix Proteins, Viral Structural Proteins.
- chemical , genetics : Nucleocapsid Proteins, Viral Envelope Proteins, Viral Matrix Proteins, Viral Structural Proteins.
- chemical , metabolism : Green Fluorescent Proteins.
- chemical , pharmacology : RNA, Small Interfering.
- drug effects : SARS Virus.
- genetics : SARS Virus.
- metabolism : SARS Virus.
- Animals, Chlorocebus aethiops, Cloning, Molecular, Gene Expression Regulation, Viral, RNA Interference, Vero Cells.
Abstract
RNA interference (RNAi) is triggered by the presence of a double-stranded RNA (dsRNA), and results in the silencing of homologous gene expression through the specific degradation of an mRNA containing the same sequence. dsRNA-mediated RNAi can be used in a wide variety of eucaryotes to induce the sequence-specific inhibition of gene expression. Synthetic 21-23 nucleotide (nt) small interfering RNA (siRNA) with 2 nt 3' overhangs was recently found to mediate efficient sequence-specific mRNA degradation in mammalian cells. Here, we studied the effects of synthetic siRNA duplexes targeted to SARS coronavirus structural proteins E, M, and N in a cell culture system. Among total 26 siRNA duplexes, we obtained 3 siRNA duplexes which could sequence-specifically reduce target genes expression over 80% at the concentration of 60 nM in Vero E6 cells. The downregulation effect was in correlation with the concentrations of the siRNA duplexes in a range of 0 approximately 60 nM. Our results also showed that many inactive siRNA duplexes may be brought to life simply by unpairing the 5'end of the antisense strands. Results suggest that siRNA is capable of inhibiting SARS coronavirus genes expression and thus may be a new therapeutic strategy for treatment of SARS.
DOI: 10.1038/sj.cr.7290286
PubMed: 15780182
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15780182Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs.</title>
<author><name sortKey="Shi, Yi" sort="Shi, Yi" uniqKey="Shi Y" first="Yi" last="Shi">Yi Shi</name>
<affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031</wicri:regionArea>
<wicri:noRegion>Shanghai 200031</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yang, De Hua" sort="Yang, De Hua" uniqKey="Yang D" first="De Hua" last="Yang">De Hua Yang</name>
</author>
<author><name sortKey="Xiong, Jie" sort="Xiong, Jie" uniqKey="Xiong J" first="Jie" last="Xiong">Jie Xiong</name>
</author>
<author><name sortKey="Jia, Jie" sort="Jia, Jie" uniqKey="Jia J" first="Jie" last="Jia">Jie Jia</name>
</author>
<author><name sortKey="Huang, Bing" sort="Huang, Bing" uniqKey="Huang B" first="Bing" last="Huang">Bing Huang</name>
</author>
<author><name sortKey="Jin, You Xin" sort="Jin, You Xin" uniqKey="Jin Y" first="You Xin" last="Jin">You Xin Jin</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15780182</idno>
<idno type="pmid">15780182</idno>
<idno type="doi">10.1038/sj.cr.7290286</idno>
<idno type="wicri:Area/PubMed/Corpus">002835</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002835</idno>
<idno type="wicri:Area/PubMed/Curation">002835</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002835</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002651</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002651</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs.</title>
<author><name sortKey="Shi, Yi" sort="Shi, Yi" uniqKey="Shi Y" first="Yi" last="Shi">Yi Shi</name>
<affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031</wicri:regionArea>
<wicri:noRegion>Shanghai 200031</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yang, De Hua" sort="Yang, De Hua" uniqKey="Yang D" first="De Hua" last="Yang">De Hua Yang</name>
</author>
<author><name sortKey="Xiong, Jie" sort="Xiong, Jie" uniqKey="Xiong J" first="Jie" last="Xiong">Jie Xiong</name>
</author>
<author><name sortKey="Jia, Jie" sort="Jia, Jie" uniqKey="Jia J" first="Jie" last="Jia">Jie Jia</name>
</author>
<author><name sortKey="Huang, Bing" sort="Huang, Bing" uniqKey="Huang B" first="Bing" last="Huang">Bing Huang</name>
</author>
<author><name sortKey="Jin, You Xin" sort="Jin, You Xin" uniqKey="Jin Y" first="You Xin" last="Jin">You Xin Jin</name>
</author>
</analytic>
<series><title level="j">Cell research</title>
<idno type="ISSN">1001-0602</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Cloning, Molecular</term>
<term>Gene Expression Regulation, Viral</term>
<term>Green Fluorescent Proteins (metabolism)</term>
<term>Nucleocapsid Proteins (antagonists & inhibitors)</term>
<term>Nucleocapsid Proteins (biosynthesis)</term>
<term>Nucleocapsid Proteins (genetics)</term>
<term>RNA Interference</term>
<term>RNA, Small Interfering (pharmacology)</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (metabolism)</term>
<term>Vero Cells</term>
<term>Viral Envelope Proteins (antagonists & inhibitors)</term>
<term>Viral Envelope Proteins (biosynthesis)</term>
<term>Viral Envelope Proteins (genetics)</term>
<term>Viral Matrix Proteins (antagonists & inhibitors)</term>
<term>Viral Matrix Proteins (biosynthesis)</term>
<term>Viral Matrix Proteins (genetics)</term>
<term>Viral Structural Proteins (antagonists & inhibitors)</term>
<term>Viral Structural Proteins (biosynthesis)</term>
<term>Viral Structural Proteins (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Cellules Vero</term>
<term>Clonage moléculaire</term>
<term>Interférence par ARN</term>
<term>Petit ARN interférent (pharmacologie)</term>
<term>Protéines de l'enveloppe virale (antagonistes et inhibiteurs)</term>
<term>Protéines de l'enveloppe virale (biosynthèse)</term>
<term>Protéines de l'enveloppe virale (génétique)</term>
<term>Protéines de la matrice virale (antagonistes et inhibiteurs)</term>
<term>Protéines de la matrice virale (biosynthèse)</term>
<term>Protéines de la matrice virale (génétique)</term>
<term>Protéines nucléocapside (antagonistes et inhibiteurs)</term>
<term>Protéines nucléocapside (biosynthèse)</term>
<term>Protéines nucléocapside (génétique)</term>
<term>Protéines virales structurales (antagonistes et inhibiteurs)</term>
<term>Protéines virales structurales (biosynthèse)</term>
<term>Protéines virales structurales (génétique)</term>
<term>Protéines à fluorescence verte (métabolisme)</term>
<term>Régulation de l'expression des gènes viraux</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (génétique)</term>
<term>Virus du SRAS (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Nucleocapsid Proteins</term>
<term>Viral Envelope Proteins</term>
<term>Viral Matrix Proteins</term>
<term>Viral Structural Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Nucleocapsid Proteins</term>
<term>Viral Envelope Proteins</term>
<term>Viral Matrix Proteins</term>
<term>Viral Structural Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Nucleocapsid Proteins</term>
<term>Viral Envelope Proteins</term>
<term>Viral Matrix Proteins</term>
<term>Viral Structural Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Green Fluorescent Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>RNA, Small Interfering</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Protéines de l'enveloppe virale</term>
<term>Protéines de la matrice virale</term>
<term>Protéines nucléocapside</term>
<term>Protéines virales structurales</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Protéines de l'enveloppe virale</term>
<term>Protéines de la matrice virale</term>
<term>Protéines nucléocapside</term>
<term>Protéines virales structurales</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Protéines de l'enveloppe virale</term>
<term>Protéines de la matrice virale</term>
<term>Protéines nucléocapside</term>
<term>Protéines virales structurales</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Protéines à fluorescence verte</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Petit ARN interférent</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Cloning, Molecular</term>
<term>Gene Expression Regulation, Viral</term>
<term>RNA Interference</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Cellules Vero</term>
<term>Clonage moléculaire</term>
<term>Interférence par ARN</term>
<term>Régulation de l'expression des gènes viraux</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">RNA interference (RNAi) is triggered by the presence of a double-stranded RNA (dsRNA), and results in the silencing of homologous gene expression through the specific degradation of an mRNA containing the same sequence. dsRNA-mediated RNAi can be used in a wide variety of eucaryotes to induce the sequence-specific inhibition of gene expression. Synthetic 21-23 nucleotide (nt) small interfering RNA (siRNA) with 2 nt 3' overhangs was recently found to mediate efficient sequence-specific mRNA degradation in mammalian cells. Here, we studied the effects of synthetic siRNA duplexes targeted to SARS coronavirus structural proteins E, M, and N in a cell culture system. Among total 26 siRNA duplexes, we obtained 3 siRNA duplexes which could sequence-specifically reduce target genes expression over 80% at the concentration of 60 nM in Vero E6 cells. The downregulation effect was in correlation with the concentrations of the siRNA duplexes in a range of 0 approximately 60 nM. Our results also showed that many inactive siRNA duplexes may be brought to life simply by unpairing the 5'end of the antisense strands. Results suggest that siRNA is capable of inhibiting SARS coronavirus genes expression and thus may be a new therapeutic strategy for treatment of SARS.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15780182</PMID>
<DateCompleted><Year>2005</Year>
<Month>12</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1001-0602</ISSN>
<JournalIssue CitedMedium="Print"><Volume>15</Volume>
<Issue>3</Issue>
<PubDate><Year>2005</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Cell research</Title>
<ISOAbbreviation>Cell Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs.</ArticleTitle>
<Pagination><MedlinePgn>193-200</MedlinePgn>
</Pagination>
<Abstract><AbstractText>RNA interference (RNAi) is triggered by the presence of a double-stranded RNA (dsRNA), and results in the silencing of homologous gene expression through the specific degradation of an mRNA containing the same sequence. dsRNA-mediated RNAi can be used in a wide variety of eucaryotes to induce the sequence-specific inhibition of gene expression. Synthetic 21-23 nucleotide (nt) small interfering RNA (siRNA) with 2 nt 3' overhangs was recently found to mediate efficient sequence-specific mRNA degradation in mammalian cells. Here, we studied the effects of synthetic siRNA duplexes targeted to SARS coronavirus structural proteins E, M, and N in a cell culture system. Among total 26 siRNA duplexes, we obtained 3 siRNA duplexes which could sequence-specifically reduce target genes expression over 80% at the concentration of 60 nM in Vero E6 cells. The downregulation effect was in correlation with the concentrations of the siRNA duplexes in a range of 0 approximately 60 nM. Our results also showed that many inactive siRNA duplexes may be brought to life simply by unpairing the 5'end of the antisense strands. Results suggest that siRNA is capable of inhibiting SARS coronavirus genes expression and thus may be a new therapeutic strategy for treatment of SARS.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shi</LastName>
<ForeName>Yi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yang</LastName>
<ForeName>De Hua</ForeName>
<Initials>DH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Xiong</LastName>
<ForeName>Jie</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jia</LastName>
<ForeName>Jie</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Bing</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jin</LastName>
<ForeName>You Xin</ForeName>
<Initials>YX</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Cell Res</MedlineTA>
<NlmUniqueID>9425763</NlmUniqueID>
<ISSNLinking>1001-0602</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C501689">E protein, SARS coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019590">Nucleocapsid Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014763">Viral Matrix Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015678">Viral Structural Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C099602">nucleocapsid protein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>108502-71-2</RegistryNumber>
<NameOfSubstance UI="C067997">M protein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>147336-22-9</RegistryNumber>
<NameOfSubstance UI="D049452">Green Fluorescent Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015967" MajorTopicYN="N">Gene Expression Regulation, Viral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D049452" MajorTopicYN="N">Green Fluorescent Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019590" MajorTopicYN="N">Nucleocapsid Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D034622" MajorTopicYN="Y">RNA Interference</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014763" MajorTopicYN="N">Viral Matrix Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015678" MajorTopicYN="N">Viral Structural Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>3</Month>
<Day>23</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>12</Month>
<Day>13</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>3</Month>
<Day>23</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15780182</ArticleId>
<ArticleId IdType="doi">10.1038/sj.cr.7290286</ArticleId>
<ArticleId IdType="pmc">PMC7091820</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2014-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12566571</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Hepatology. 2003 Apr;37(4):764-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12668968</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2783-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12594341</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 2002 Nov 1;169(9):5196-201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12391237</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell. 2003 Oct 17;115(2):209-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14567918</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2000 Feb;74(3):1393-406</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10627550</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell. 2003 Oct 17;115(2):199-208</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14567917</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>FEBS Lett. 2004 Feb 27;560(1-3):141-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14988013</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1779-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781537</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMJ. 2004 Jan 10;328(7431):65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14715581</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Genes Dev. 2001 Jan 15;15(2):188-200</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11157775</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2001 Jun 22;292(5525):2277-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11423650</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>EMBO J. 2001 Dec 3;20(23):6877-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11726523</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2002 Dec;76(24):12963-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12438622</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Methods. 2002 Feb;26(2):199-213</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12054897</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2002 Jul 25;418(6896):379-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12140542</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Oct 4;362(9390):1159</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14550718</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2002 Jul 25;418(6896):430-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12087357</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2718-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12594334</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14147-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10570213</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell. 2000 Mar 31;101(1):25-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10778853</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Genet. 2002 Oct;3(10):737-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12360232</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2002 Sep;76(18):9225-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12186906</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Plant Cell. 1993 Dec;5(12):1749-1759</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12271055</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Genet. 2001 Feb;2(2):110-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11253050</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2003 Dec;84(Pt 12):3291-3303</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14645910</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Dec 6;362(9399):1895-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14667748</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Biotechnol. 2003 Jun;21(6):639-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12740585</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2004 Mar;10(3):290-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14981511</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14983044</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):235-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12518066</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
</list>
<tree><noCountry><name sortKey="Huang, Bing" sort="Huang, Bing" uniqKey="Huang B" first="Bing" last="Huang">Bing Huang</name>
<name sortKey="Jia, Jie" sort="Jia, Jie" uniqKey="Jia J" first="Jie" last="Jia">Jie Jia</name>
<name sortKey="Jin, You Xin" sort="Jin, You Xin" uniqKey="Jin Y" first="You Xin" last="Jin">You Xin Jin</name>
<name sortKey="Xiong, Jie" sort="Xiong, Jie" uniqKey="Xiong J" first="Jie" last="Xiong">Jie Xiong</name>
<name sortKey="Yang, De Hua" sort="Yang, De Hua" uniqKey="Yang D" first="De Hua" last="Yang">De Hua Yang</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Shi, Yi" sort="Shi, Yi" uniqKey="Shi Y" first="Yi" last="Shi">Yi Shi</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002651 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002651 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:15780182 |texte= Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15780182" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |